WST Stock: West Pharmaceutical Services, Inc. Stock Price, Analysis & Insights
Get live wst stock price $271.04, comprehensive West Pharmaceutical Services, Inc. stock analysis, charts, news, and expert forecast. Real-time wst stock data and investment insights.
Loading chart...
Company Overview
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Company Information
- CEO
- Eric M. Green
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 10600
Contact Information
- Website
- https://www.westpharma.com
- Address
- 530 Herman O. West Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 40.1)
Business Model & Strategy
West Pharmaceutical Services, Inc. operates in the Medical - Instruments & Supplies industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Eric M. Green, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Instruments & Supplies model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
West Pharmaceutical Services, Inc. competes in the Medical - Instruments & Supplies within the broader Healthcare. With 19.5 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, West Pharmaceutical Services, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating West Pharmaceutical Services, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for West Pharmaceutical Services, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for West Pharmaceutical Services, Inc.
- ⚠Investors should consider how West Pharmaceutical Services, Inc. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 40.1) requires strong growth to justify
Market Cap
19.50B
P/E Ratio
40.15
Beta
1.17
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 19.50B market capitalization
- Trading Volume: 856.21K shares traded today
- Price Range: 52-week range of $187.43 - $348.90
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) operates in the Medical - Instruments & Supplies industry within the Healthcare sector. With a current market capitalization of 19.50B, the company represents a significant player in its market. The stock is currently trading at $271.04 with a negativedaily change of 1.56%.
The company's 10600 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 40.15, beta of 1.17, and 52-week price range from $187.43 to $348.90when evaluating investment opportunities.
Why Invest in West Pharmaceutical Services, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Eric M. Green
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.